In:
Digestive Diseases, S. Karger AG, Vol. 36, No. 4 ( 2018), p. 271-280
Abstract:
〈 b 〉 〈 i 〉 Background and Aim: 〈 /i 〉 〈 /b 〉 To evaluate the usefulness of a low FODMAP (Fermentable Oligosaccharides, Disaccharides, Monosaccharides, and Polyols) diet on patients with irritable bowel syndrome (IBS), non-active inflammatory bowel diseases (IBD), and celiac disease (CD) on a gluten-free diet (GFD). 〈 b 〉 〈 i 〉 Methods: 〈 /i 〉 〈 /b 〉 Dietetic interventional prospective study. IBS, IBD, and CD subjects were evaluated to check if they fulfilled the Rome III criteria. Each subject was educated to follow a low FODMAP diet after being evaluated by filling out questionnaires that assessed the quality of life (QoL) and symptoms experienced (IBS-SSS and SF-36), and was reevaluated after 1 and 3 months. 〈 b 〉 〈 i 〉 Results: 〈 /i 〉 〈 /b 〉 One hundred twenty-seven subjects were enrolled: 56 with IBS, 30 with IBD, and 41 with CD. IBS-SSS showed that abdominal symptoms improved after 1 and 3 months of diet in all subjects, with significant difference among the 3 groups at T0 (average scores IBS: 293 ± 137, IBD: 206 ± 86, CD: 222 ± 65, 〈 i 〉 p 〈 /i 〉 & #x3c; 0.001), but no difference at T3 (IBS: 88 ± 54, IBD: 73 ± 45, CD: 77 ± 49, 〈 i 〉 p 〈 /i 〉 = ns). By analyzing the SF-36 questionnaire, we did not observe any difference between the 3 groups, in terms of response to diet ( 〈 i 〉 p 〈 /i 〉 = ns), we observed a clinical improvement from T0 to T3 for most of the questionnaire’s domains. 〈 b 〉 〈 i 〉 Conclusions: 〈 /i 〉 〈 /b 〉 A low FODMAP diet could be a valid option to counter abdominal symptoms in patients with IBS, non-active IBD, or CD on a GFD, and thus, improve their QoL and social relations.
Type of Medium:
Online Resource
ISSN:
0257-2753
,
1421-9875
Language:
English
Publisher:
S. Karger AG
Publication Date:
2018
detail.hit.zdb_id:
1482221-0
Permalink